The
merger of photoredox catalysis with transition metal catalysis,
termed metallaphotoredox catalysis, has become a mainstay in synthetic
methodology over the past decade. Metallaphotoredox catalysis has
combined the unparalleled capacity of transition metal catalysis for
bond formation with the broad utility of photoinduced electron- and
energy-transfer processes. Photocatalytic substrate activation has
allowed the engagement of simple starting materials in metal-mediated
bond-forming processes. Moreover, electron or energy transfer directly
with key organometallic intermediates has provided novel activation
modes entirely complementary to traditional catalytic platforms. This
Review details and contextualizes the advancements in molecule construction
brought forth by metallaphotocatalysis.
Alkyl chlorides are bench-stable chemical feed-stocks that remain among the most underutilized electrophile classes in transition metal catalysis. Overcoming intrinsic limitations of C(sp 3 )-Cl bond activation, we report the development of a novel organosilane reagent that can participate in chlorine atom abstraction under mild photocatalytic conditions. In particular, we describe the application of this mechanism to a dual nickel/photoredox catalytic protocol that enables the first cross-electrophile coupling of unactivated alkyl chlorides and aryl chlorides. Employing these low toxicity, abundant, and commercially available organochloride building blocks, this methodology allows access to a broad array of highly functionalized C(sp 2 )-C(sp 3 ) coupled adducts, including numerous drug analogs.
Alcohols
and carboxylic acids are among the most commercially abundant,
synthetically versatile, and operationally convenient functional groups
in organic chemistry. Under visible light photoredox catalysis, these
native synthetic handles readily undergo radical activation, and the
resulting open-shell intermediates can subsequently participate in
transition metal catalysis. In this report, we describe the C(sp
3)–C(sp
3) cross-coupling of alcohols and carboxylic acids through the dual
combination of N-heterocyclic carbene (NHC)-mediated
deoxygenation and hypervalent iodine-mediated decarboxylation. This
mild and practical Ni-catalyzed radical-coupling protocol was employed
to prepare a wide array of alkyl–alkyl cross-coupled products,
including highly congested quaternary carbon centers from the corresponding
tertiary alcohols or tertiary carboxylic acids. We demonstrate the
synthetic applications of this methodology to alcohol C
1-alkylation and formal homologation, as well as to the
late-stage functionalization of drugs, natural products, and biomolecules.
The rapid exploration of sp3‐enriched chemical space is facilitated by fragment‐coupling technologies that utilize simple and abundant alkyl precursors, among which alcohols are a highly desirable, commercially accessible, and synthetically versatile class of substrate. Herein, we describe an operationally convenient, N‐heterocyclic carbene (NHC)‐mediated deoxygenative Giese‐type addition of alcohol‐derived alkyl radicals to electron‐deficient alkenes under mild photocatalytic conditions. The fragment coupling accommodates a broad range of primary, secondary, and tertiary alcohol partners, as well as structurally varied Michael acceptors containing traditionally reactive sites, such as electrophilic or oxidizable moieties. We demonstrate the late‐stage diversification of densely functionalized molecular architectures, including drugs and biomolecules, and we further telescope our protocol with metallaphotoredox cross‐coupling for step‐economic access to sp3‐rich complexity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.